Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. GDRX
GDRX logo

GDRX News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

GDRX News

Hims & Hers Health Continues to Outperform GoodRx in Revenue Growth

4h agoNASDAQ.COM

GoodRx and Hims & Hers Financial Report Analysis

4h agoFool

GoodRx vs Hims & Hers: Revenue Stagnation vs Growth

4h agoYahoo Finance

GoodRx Q1 2026 Earnings Call Highlights

2d agoseekingalpha

GoodRx Q1 Earnings Beat Expectations Amid Revenue Decline

3d agoseekingalpha

GoodRx Launches Oral Ozempic® Treatment for Diabetes

May 01 2026Newsfilter

GOODRX HOLDINGS INC - INCREASES AVAILABILITY OF OZEMPIC PILL STARTING AT $149 PER MONTH

May 01 2026moomoo

GoodRx Launches FDA-Approved Foundayo Medication for Weight Management

Apr 09 2026Newsfilter

GDRX Events

05/06 17:10
Raises FY26 Adjusted EBITDA Outlook to Over $235M
Consensus $764.78M. Raises FY26 adjusted EBITDA view to over $235M from over $230M.
05/06 17:10
GoodRx Q1 Revenue $194M Beats Expectations
Reports Q1 revenue $194M, consensus $185.12M. "We delivered a strong start to the year, with continued momentum across our strategic growth priorities," said Wendy Barnes, President and Chief Executive Officer of GoodRx. "Our results demonstrate that the strategy we laid out last quarter is working and that we are building a sustainable value proposition. We believe that momentum is driving durable growth and increasing value for consumers and our partners."
05/06 14:50
Notable Companies Earnings Consensus: Arm 58c, AppLovin $3.64
Notable companies reporting after the market close, with earnings consensus, include Arm (ARM), consensus 58c... AppLovin (APP), consensus $3.64... DoorDash (DASH), consensus $1.07... Warner Bros. Discovery (WBD), consensus (10c)... Coherent (COHR), consensus $1.39... Fortinet (FTNT), consensus 62c... Snap (SNAP), consensus 10c... Zillow (ZG), consensus 46c... Paycom (PAYC), consensus $2.99... GoodRX (GDRX), consensus 7c.

GDRX Monitor News

No data

No data

GDRX Earnings Analysis

No Data

No Data

People Also Watch